Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2

QR Code

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2

The present article describes clinical signs of meningococcal disease. It justifies the necessity of its vaccine prevention. The article provides with the historical data on the evolution of inoculants from corpuscular inactivated vaccines to modern chemical polyvalent vaccines. It provides a glimps...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Abramtseva, A. P. Tarasov, T. I. Nemirovskaya
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:	Биопрепараты: Профилактика, диагностика, лечение
Subjects:	менингококковая инфекция генерализированные формы менингококковой инфекции менингококковый менингит капсульные полисахариды менингококковые вакцины реактогенность иммуногенность протективный иммунитет полисахаридные вакцины meningococcal disease generalized forms of meningococcal disease meningococcal meningitis capsular polysaccharides meningococcal vaccines reactivity immunogenicity protective immunity polysaccharide vaccines
Online Access:	https://www.biopreparations.ru/jour/article/view/19
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Current Meningococcal Vaccines: Advantages and Disadvantages and New Challenges
by: N. N. Kostyukova, et al.
Published: (2016-08-01)

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Meningococcal Vaccines of New Generations – the First 20 Years of Use
by: N. N. Kostyukova, et al.
Published: (2021-09-01)

Safety and Immunogenicity of Meningococcal Groups A and C Polysaccharide Vaccine in Adults 18–60 years of age
by: V. V. Romanenko, et al.
Published: (2023-11-01)

Heart damage during meningococcal infection
by: A. A. Grishaeva, et al.
Published: (2024-12-01)

Meningococcal Urethritis: an additional Source of Meningococcal Disease?
by: N. N. Kostyukova, et al.
Published: (2020-07-01)

<i>Haemophilus</i><i> influenzae</i> type <i>b</i>. Incidence rate and preventive vaccination
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

The important lessons lurking in the history of meningococcal epidemiology
by: Ray Borrow, et al.
Published: (2024-12-01)

EPIDEMIOLOGY AND PREVENTION OF MENINGOCOCCAL DISEASE: A CRITICAL APPRAISAL OF VACCINE POLICIES
by: Marco AP Safadi, et al.
Published: (2012-02-01)

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
by: I. S. Koroleva, et al.
Published: (2022-01-01)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-06-01)

The Safety of 4-valent Meningococcal Conjugate Vaccine in Two Years Old Children: Prospective Cohort Study in Sakhalin Region
by: Oxana V. Solonina, et al.
Published: (2019-09-01)

Past, present, and future policy considerations regarding meningococcal vaccination in the United States
by: Diana E. Clements, et al.
Published: (2024-12-01)

Serogroup B Protein Meningococcal Vaccines and the Formation of Immune Protection against Gonorrhea
by: N. N. Kostyukova, et al.
Published: (2024-07-01)

Dynamics (2014-2019) of Tetravalent Vaccines Against Meningococcal Infection Serogroups A, C, Y and W-135 Use: Prospective Study of Series of Cases Followed by the Monitoring of the Immunization Safety (Using the Conjugate Vaccine as the Example)
by: Diana V. Sutovskaya, et al.
Published: (2020-04-01)

Meningococcal infection in children: factors influencing outcome
by: O. V. Samodova, et al.
Published: (2019-10-01)

Meningococcal Carriage: Epidemiology, Causative Agent, Inducing of Immune Protection
by: N. N. Kostyukova, et al.
Published: (2017-10-01)

Meningococcal Infection in Novosibirsk: Changes in Epidemiology and Prevention Problems
by: I. Ya. Izvekova, et al.
Published: (2021-07-01)

The Level of Meningococcal Carriage and Genotyping of N. meningitidis Strains in the Group of Labor Migrants
by: M. A. Koroleva, et al.
Published: (2020-11-01)

Evaluation of the potential economic effects in the increased vaccination against meningococcal infection based on real epidemiological data
by: S. V. Svetlichnaya, et al.
Published: (2023-08-01)

Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-12-01)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India
by: O. A. Perminova, et al.
Published: (2020-05-01)

Public Health Impact of Potential Infant MenACWY Vaccination Strategies in Spain
by: Katharina Schley, et al.
Published: (2025-06-01)

Generalized Meningococcal Disease in the Newborn: Clinical Case and Literature Review
by: Irina Ya. Izvekova
Published: (2023-05-01)

Epidemiological Characteristics of Meningococcal Infection in Moscow
by: M. I. Gritsay, et al.
Published: (2020-05-01)

Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Russian Federation
by: I. Ya. Izvekova, et al.
Published: (2019-01-01)

The development and certification of the industrial reference standard for identification of meningococcal polysaccharide vaccine group A
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Estimation of the Potential Benefits of Meningococcal Vaccination in Children at 9 and 12 Months of Age Using a Predictive Mathematical Model
by: N. I. Briko, et al.
Published: (2020-11-01)

Herpesviruses, as a possible cause complicated course of invasive meningococcal disease (clinical case)
by: N. V. Skripchenko, et al.
Published: (2016-07-01)

Unusual course of meningococcal infection with lethal outcome (brief communication)
by: V. A. Zinserling, et al.
Published: (2023-07-01)

Clinical-epidemiological features of meningococcal infection in children during sporadic morbidity
by: G. P. Martynova, et al.
Published: (2015-07-01)

Clinical and epidemiological aspects of generalized meningococcal infections in children and adolescents of Saint-Petersburg
by: Yu. V. Lobzin, et al.
Published: (2016-04-01)

Primary (isolated) meningococcal pericarditis caused by <i>N. meningitidis</i>: case report
by: O. O. Chernysheva, et al.
Published: (2025-03-01)

The Susceptibility of Meningococci to the Antimicrobial Agents in Moscow 2006 - 2015
by: M. A. Koroleva, et al.
Published: (2016-06-01)

Epidemiology and Regional Programs on Meningococcal Disease Prevention in Tyumen Region and Yamalo-Nenets Autonomous District
by: Olga A. Richkova, et al.
Published: (2020-06-01)

Meningococcal infection in children in the period 2012–2021. Main results of a retrospective multicenter study, issues of the day
by: A. A. Vilnits, et al.
Published: (2024-01-01)

Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study
by: L. S. Namazova-Baranova, et al.
Published: (2023-01-01)

Results of clinical trial in Russia to assess immunological efficacy and safety of meningococcal vaccine (serogroups A, C, Y, W, X) in adults
by: I. V. Fel'dblyum, et al.
Published: (2025-07-01)

Safety of Tetravalent Conjugate Meningococcal Vaccine (Serotypes A, C, Y, W) for 1–4 Years Old Children With Distresses and Chronic Diseases in Closed Healthcare Facility: Cohort Study
by: Alebai U. Sabitov, et al.
Published: (2019-12-01)

Epidemiology of invasive meningococcal disease in Novosibirsk region during 1992–2015
by: I. Ya. Izvekova, et al.
Published: (2016-11-01)